EHA Bilateral Collaborative Grant

The call for applications will close on October 15, 2024, at 15:00 (CEST).  Apply now

The EHA Bilateral Collaborative Grant supports collaboration between two independent research groups:

  • With complementarity of expertise
  • Showing a mutual need to answer a specific research question

The grant:

  • Lasts for a period of two years
  • Provides an annual financial award of at €160,000 to be divided equally between the two research groups


General criteria

You must be an EHA member or EHA guest to apply for an EHA Bilateral Collaborative Grant.

You can be of any nationality, but both institutes must be academic research centers or proven equivalent and located in Europe.

In all cases, your application must:

  • Have the support of an academic department and institute
  • Relate to basic and translational lab-based research in hematology

Specific criteria

  • The two principal investigators (PIs) must be basic and/or translational researchers.
  • The two PIs must be independent researchers or group leaders and have full appointments at academic institutes or proven equivalents.
  • The two PIs must conduct their research in two different European countries.
  • At least one of the PIs must be a junior independent group leader, within five years of conducting independent research.
  • If an applicant is a physician scientist, at least 50% of their time should be dedicated to lab research.

Eligible proposals

Your application will not be eligible if it relates to:

  • Purely clinical research projects
  • Projects in health economics
  • Other non-lab-based research

Topic-in-Focus Research Grant in Precision Hematology

A Topic-in-Focus Research Grant in Precision Hematology is a separate category of an EHA Bilateral Collaborative Grant.

It promotes innovative concepts for diagnostics and clinical trial designs—with a concrete view to translation into clinical application in precision hematology.

This grant is suitable for researchers whose focus is on translational science in malignant hematology—to address urgent medical needs in rare diseases with precision medicine approaches.

Proposals should aim to achieve at least one of the following:

  • Establish new principles or platforms to define biomarkers that may guide treatment interventions
  • Develop methodologies for assessing new functional and/or predictive biomarkers with the goal of guiding treatment interventions
  • Undertake pilot biomarker studies within a clinical trial to evaluate biomarker effectiveness.

This grant will not fund proposals on:

  • Molecular profiling of disease entities for classification or stratification
  • Validating established diagnostic methodologies
  • Performing molecular, functional, or other systematic (proteomics, metabolomics, dependency mapping) screenings.

To apply, select the ‘Topic-in-Focus’ option in your application form.

If you have questions about your eligibility, you can contact us at before submitting an application.

What the grant covers

For guidance on what you can you do with the funds, read our page about how you can use an EHA Bilateral Collaborative Grant.

How to apply

If you want to submit an application, read our EHA Bilateral Collaborative Grant application guidance.